中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Application of Epigenome-Modifying Small Molecules in Induced Pluripotent Stem Cells

文献类型:期刊论文

作者Lu, Junyan1,2; Kong, Xiangqian1,3; Luo, Cheng1,2; Li, Keqin Kathy3
刊名MEDICINAL RESEARCH REVIEWS
出版日期2013-07
卷号33期号:4页码:790-822
关键词induced pluripotent stem cells epigenetics DNA methylation histone modification small molecule inhibitor
ISSN号0198-6325
DOI10.1002/med.21265
文献子类Review
英文摘要Recent breakthroughs in generating induced pluripotent stem cells (iPSCs) using four defined factors have revealed the potential utility of stem cells in biological research and clinical applications. However, the low efficiency and slow kinetics of reprogramming related to producing these cells and underlying safety issues, such as viral integration and genetic and epigenetic abnormalities of iPSCs, hamper the further application of iPSCs in laboratory and clinical settings. Previous studies have suggested that reprogramming efficiency can be enhanced and that reprogramming kinetics can be accelerated by manipulating epigenetic status. Herein, we review recent studies on the application of epigenome-modifying small molecules in enhancing reprogramming and functionally replacing some reprogramming factors. We mainly focus on studies that have used small molecules to interfere with epigenome-modifying enzymes, such as DNA methyltransferase, histone acetyltransferase, and histone methyltransferase. The potential use of these small molecules in inducing iPSCs and new ways to identify small molecules of higher potency and fewer side effects are also discussed.
WOS关键词HISTONE-H3 LYSINE-9 METHYLATION ; DNA METHYLATION ; DEACETYLASE INHIBITORS ; EPIGENETIC REGULATION ; CHROMATIN-STRUCTURE ; HUMAN FIBROBLASTS ; GENE-EXPRESSION ; VALPROIC ACID ; SENDAI-VIRUS ; ACETYLATION
资助项目State Key Program of Basic Research of China[2009CB918502] ; State Key Program of Basic Research of China[2011CB510102] ; National Natural Science Foundation of China[20972174] ; National Natural Science Foundation of China[21021063] ; National Natural Science Foundation of China[91029704] ; 863 program[2012AA020302] ; Chinese Academy of Sciences[XDA01040305]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000319988700003
出版者WILEY
源URL[http://119.78.100.183/handle/2S10ELR8/277575]  
专题药物发现与设计中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Li, Keqin Kathy
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China;
2.Soochow Univ, Sch Elect & Informat Engn, Ctr Syst Biol, Suzhou, Peoples R China;
3.Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, Shanghai 200030, Peoples R China
推荐引用方式
GB/T 7714
Lu, Junyan,Kong, Xiangqian,Luo, Cheng,et al. Application of Epigenome-Modifying Small Molecules in Induced Pluripotent Stem Cells[J]. MEDICINAL RESEARCH REVIEWS,2013,33(4):790-822.
APA Lu, Junyan,Kong, Xiangqian,Luo, Cheng,&Li, Keqin Kathy.(2013).Application of Epigenome-Modifying Small Molecules in Induced Pluripotent Stem Cells.MEDICINAL RESEARCH REVIEWS,33(4),790-822.
MLA Lu, Junyan,et al."Application of Epigenome-Modifying Small Molecules in Induced Pluripotent Stem Cells".MEDICINAL RESEARCH REVIEWS 33.4(2013):790-822.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。